Evidence map›Paper›PMID 30857538›Full record

ArticleMicrobial cell factories2019

Screening and purification of nanobodies from E. coli culture supernatants using the hemolysin secretion system.

David Ruano-Gallego, Sofía Fraile, Carlos Gutierrez, Luis Ángel Fernández

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Engineering a Novel Probiotic Toolkit inACS synthetic biology · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. NANOBODIES®: A Review of Diagnostic and Therapeutic ApplicationsInternational journal of molecular sciences · 2023
    Review
  13. Article
  14. Article
  15. Bioactive VEGF-C from E. coli.Scientific reports · 2022
    Article
  16. Fluorescent labeling of genomic loci inCell reports methods · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

David Ruano-GallegoDepartment of Microbial Biotechnology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Campus UAM-Cantoblanco, 28049, Madrid, Spain.
Sofía FraileDepartment of Microbial Biotechnology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Campus UAM-Cantoblanco, 28049, Madrid, Spain.
Carlos GutierrezResearch Institute of Biomedical and Health Sciences, Veterinary Faculty, Universidad de Las Palmas de Gran Canaria (UPGC), 35413, Arucas, Las Palmas, Canary Islands, Spain.
Luis Ángel FernándezDepartment of Microbial Biotechnology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas (CSIC), Campus UAM-Cantoblanco, 28049, Madrid, Spain. lafdez@cnb.csic.es.ORCID http://orcid.org/0000-0001-5920-0638
Consejo Superior de Investigaciones Científicas · ESUniversidad de Las Palmas de Gran Canaria · ES

Funding

FLAT PANEL CONE BEAM CT FOR IMAGE GUIDED RADIOTHERAPYR01CA089081 · NCI · WILLIAM BEAUMONT HOSPITAL RESEARCH INST · PI JAFFRAY, DAVID A · 2001 to 2002
$492k
Agencia Estatal de Investigación BIO2017-89081-R (AEI/MICIU/FEDER, EU)European Research Council ERC-2012-ADG_20120314Wellcome TrustWellcome Trust LCCM_P59474
6 · The paper itself

Abstract

backgroundThe hemolysin (Hly) secretion system of E. coli allows the one-step translocation of hemolysin A (HlyA) from the bacterial cytoplasm to the extracellular medium, without a periplasmic intermediate. In this work, we investigate whether the Hly secretion system of E. coli is competent to secrete a repertoire of functional single-domain VHH antibodies (nanobodies, Nbs), facilitating direct screening of VHH libraries and the purification of selected Nb from the extracellular medium.

resultsWe employed a phagemid library of VHHs obtained by immunization of a dromedary with three protein antigens from enterohemorrhagic E. coli (EHEC), namely, the extracellular secreted protein A (EspA), the extracellular C-terminal region of Intimin (Int280), and the translocated intimin receptor middle domain (TirM). VHH clones binding each antigen were enriched and amplified by biopanning, and subsequently fused to the C-terminal secretion signal of HlyA to be expressed and secreted in a E. coli strain carrying the Hly export machinery (HlyB, HlyD and TolC). Individual E. coli clones were grown and induced in 96-well microtiter plates, and the supernatants of the producing cultures directly used in ELISA for detection of Nbs binding EspA, Int280 and TirM. A set of Nb sequences specifically binding each of these antigens were identified, indicating that the Hly system is able to secrete a diversity of functional Nbs. We performed thiol alkylation assays demonstrating that Nbs are correctly oxidized upon secretion, forming disulphide bonds between cysteine pairs despite the absence of a periplasmic intermediate. In addition, we show that the secreted Nb-HlyA fusions can be directly purified from the supernatant of E. coli cultures, avoiding cell lysis and in a single affinity chromatography step.

conclusionsOur data demonstrate the Hly secretion system of E. coli can be used as an expression platform for screening and purification of Nb binders from VHH repertories.

Indexed as

Biological TransportCulture MediaEscherichia coliHemolysin ProteinsSingle-Domain AntibodiesCulture MediaHemolysin ProteinsSingle-Domain AntibodiesE. coli/hemolysinNanobodiesProtein secretionSingle-domain antibodies

Identifiers

PMID30857538
PMCPMC6410518
OpenAlexW2922935831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.